Drugs of this class, which are used in the treatment of type II diabetes, include Galvus (vildagliptin), Januvia (sitagliptin), Onglyza (saxagliptin), Trajenta (linagliptin), and the combination tablets Eucreas (metformin + vildagliptin), Janumet (metformin + sitagliptin) and Jentadueto (metformin + linagliptin).
When to suspect pancreatitis
Characteristic symptoms of acute pancreatitis include persistent, severe abdominal pain, sometimes radiating to the back. The that all patients taking a DPP4 inhibitor should be informed of these symptoms and encouraged to report any occurrence. Treatment should be discontinued if pancreatitis is suspected.